Zidovudine: a targeted therapy for endemic Burkitt's lymphoma
Background: Although cyclophosphamide based regimens can produce remission rates approaching 60 to 80% in endemic Burkitts lymphoma, relapses and refractory disease are fairly common in developing countries, due to advanced stage disease and ...
W Harrington +9 more
core +1 more source
Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial [PDF]
OBJECTIVES: To respond to the primary safety objective of the Perinatal HIV Prevention Trial 1 (PHPT-1) by studying the evolution of haematological parameters according to zidovudine exposure duration in HIV-1-infected pregnant women. DESIGN: Multicenter,
Lallemant, Marc +9 more
core +2 more sources
An on‐resin dual‐modification strategy for peptides is presented, comprising S‐alkynylation of peptide thiosulfonates and regioselective iridium‐catalyzed azide–thioalkyne cycloaddition. This method reliably provides access to peptides with intricate non‐canonical modifications, being compatible with complex peptides, alkynes and azides.
Marius Werner +5 more
wiley +1 more source
Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: Prevalence and metabolic consequences [PDF]
Lipoatrophy and metabolic complications of treatment of human immunodeficiency virus (HIV) infection may share common associations with adipose tissue pathology and inflammation.
McKinnon, E., Nolan, D., Hammond, E.L.
core
Zidovudine-induced myopathy: A study in Indian patients
Context: Literature is replete with studies on zidovudine-induced myopathy after prolonged use (use beyond 270 days on an average). However, all these studies have been done on patients of Caucasian, American and African ethnic origin.
Ashish Bahal +2 more
core +1 more source
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
Long-term zidovudine therapy in patients with human immunodeficiency virus (HIV) infection can cause a destructive mitochondrial myopathy with histological features of ragged-red fibres (RRF) and proliferation of abnormal mitochondria.
Moraes, C T +5 more
core +1 more source
Survival in 2367 Zidovudine-Treated Patients According to Use of Other Nucleoside Analogue Drugs
To evaluate survival according to use of different nucleoside drugs in a routine clinical setting, we studied a large group of zidovudine-treated patients seen in clinics across Europe.
Court Pedersen +29 more
core +1 more source
Incidence and risk factors of anaemia among people on antiretroviral therapy in Harare
Background: Anaemia is associated with reduced quality of life and increased mortality risk among people living with HIV (PLHIV). Although antiretroviral therapy (ART) reduces the prevalence of anaemia, some patients remain at risk after commencing ART.
Linda A. Mandikiyana Chirimuta +3 more
doaj +1 more source
An HPLC method was validated to assay lamivudine and zidovudine combined in tablets. The chromatographic separation was carried out using methanol and acetate buffer pH 6.5 (50:50 v/v) and a RP-18 column, as mobile and stationary phase, respectively. The
Ruy Carlos Ruver Beck +5 more
doaj +1 more source
Effects of zidovudine on auditory functions: enzymology and oxidative stress perspectives
The biochemical effects of chronic administration of Zidovudine (commonly used as part of highly active antiretroviral therapy (HAART) for the treatment of Human Immunodeficiency Virus (HIV) type-1) therapy on the intracranial auditory relay centres ...
Adjene, JO, Nwose, Ezekiel, Igbigbi, PS
core

